Lourdes Nicolas-Betegon
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cost-effectiveness analysis of apixaban versus acetylsalicylic acid in the prevention of stroke in patients with non-valvular atrial fibrillation in Spain
Journal: Atencion primaria
Published: May 06, 2014
Cost-effectiveness analysis of dapagliflozin compared to DPP4 inhibitors and other oral antidiabetic drugs in the treatment of type-2 diabetes mellitus in Spain
Journal: Atencion primaria
Published: April 23, 2014
Cost-effectiveness Analysis Comparing Apixaban and Acenocoumarol in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation in Spain.
Journal: Revista espanola de cardiologia (English ed.)
Published: January 31, 2014
Author's answer: Pharmacoeconomic models of simulation, meta-analysis and sponsorship of the industry
Journal: Revista espanola de salud publica
Published: June 11, 2013
Budgetary impact for the National Health System of apixaban prophylaxis of venous thromboembolism in patients undergoing total knee or hip replacement
Journal: Revista espanola de salud publica
Published: January 18, 2013
Cost-effectiveness analysis of apixaban compared to dabigatran in the prevention of venous thromboembolism in patients subjected to total knee or hip replacement
Journal: Revista espanola de cirugia ortopedica y traumatologia
Published: May 22, 2012
Use of health resources and costs associated with the diagnosis and treatment of each episode of deep vein thrombosis and bleeding in patients undergoing orthopaedic surgery for hip or knee
Journal: Revista espanola de cirugia ortopedica y traumatologia
Published: January 27, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026